Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic.
Sameh A Al-ZubiediManal Mohammed YounusSara Al-KhalidiMagnus EkiloThamir M AlshammariPublished in: Expert opinion on drug safety (2022)
The findings highlight the differences in preparedness and performance of different national PV centers in participating Arab countries. Improving digital infrastructure among participating countries could serve as a useful tool to minimize the impact of the pandemic on PV activities.